BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38250776)

  • 1. O-GlcNAcylation and Its Roles in Neurodegenerative Diseases.
    Du P; Zhang X; Lian X; Hölscher C; Xue G
    J Alzheimers Dis; 2024; 97(3):1051-1068. PubMed ID: 38250776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The emerging link between O-GlcNAcylation and neurological disorders.
    Ma X; Li H; He Y; Hao J
    Cell Mol Life Sci; 2017 Oct; 74(20):3667-3686. PubMed ID: 28534084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. O-GlcNAcylation and neurodegeneration.
    Wani WY; Chatham JC; Darley-Usmar V; McMahon LL; Zhang J
    Brain Res Bull; 2017 Jul; 133():80-87. PubMed ID: 27497832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.
    Ryan P; Xu M; Davey AK; Danon JJ; Mellick GD; Kassiou M; Rudrawar S
    ACS Chem Neurosci; 2019 May; 10(5):2209-2221. PubMed ID: 30985105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of O-GlcNAc in chronic diseases of aging.
    Banerjee PS; Lagerlöf O; Hart GW
    Mol Aspects Med; 2016 Oct; 51():1-15. PubMed ID: 27259471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-GlcNAcylation, a sweet link to the pathology of diseases.
    Nie H; Yi W
    J Zhejiang Univ Sci B; 2019 May; 20(5):437-448. PubMed ID: 31090269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental regulation of protein O-GlcNAcylation, O-GlcNAc transferase, and O-GlcNAcase in mammalian brain.
    Liu Y; Li X; Yu Y; Shi J; Liang Z; Run X; Li Y; Dai CL; Grundke-Iqbal I; Iqbal K; Liu F; Gong CX
    PLoS One; 2012; 7(8):e43724. PubMed ID: 22928023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diminished O-GlcNAcylation in Alzheimer's disease is strongly correlated with mitochondrial anomalies.
    Pinho TS; Correia SC; Perry G; Ambrósio AF; Moreira PI
    Biochim Biophys Acta Mol Basis Dis; 2019 Aug; 1865(8):2048-2059. PubMed ID: 30412792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased O-GlcNAc levels correlate with decreased O-GlcNAcase levels in Alzheimer disease brain.
    Förster S; Welleford AS; Triplett JC; Sultana R; Schmitz B; Butterfield DA
    Biochim Biophys Acta; 2014 Sep; 1842(9):1333-9. PubMed ID: 24859566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic O-GlcNAcylation and its roles in the cellular stress response and homeostasis.
    Groves JA; Lee A; Yildirir G; Zachara NE
    Cell Stress Chaperones; 2013 Sep; 18(5):535-58. PubMed ID: 23620203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. O-GlcNAc cycling: implications for neurodegenerative disorders.
    Lazarus BD; Love DC; Hanover JA
    Int J Biochem Cell Biol; 2009 Nov; 41(11):2134-46. PubMed ID: 19782947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease.
    Liu F; Shi J; Tanimukai H; Gu J; Gu J; Grundke-Iqbal I; Iqbal K; Gong CX
    Brain; 2009 Jul; 132(Pt 7):1820-32. PubMed ID: 19451179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular and extracellular O-linked N-acetylglucosamine in the nervous system.
    Ogawa M; Sawaguchi S; Kamemura K; Okajima T
    Exp Neurol; 2015 Dec; 274(Pt B):166-74. PubMed ID: 26278182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. O-GlcNAcylation in health and neurodegenerative diseases.
    Lee BE; Suh PG; Kim JI
    Exp Mol Med; 2021 Nov; 53(11):1674-1682. PubMed ID: 34837015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. O-GlcNAcylation as a Therapeutic Target for Alzheimer's Disease.
    Park J; Lai MKP; Arumugam TV; Jo DG
    Neuromolecular Med; 2020 Jun; 22(2):171-193. PubMed ID: 31894464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting O-GlcNAcylation to develop novel therapeutics.
    Zhu Y; Hart GW
    Mol Aspects Med; 2021 Jun; 79():100885. PubMed ID: 32736806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-GlcNAc and neurodegeneration: biochemical mechanisms and potential roles in Alzheimer's disease and beyond.
    Yuzwa SA; Vocadlo DJ
    Chem Soc Rev; 2014 Oct; 43(19):6839-58. PubMed ID: 24759912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Interrogation to Crack the Case of O-GlcNAc.
    Estevez A; Zhu D; Blankenship C; Jiang J
    Chemistry; 2020 Sep; 26(53):12086-12100. PubMed ID: 32207184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. O-GlcNAcylation in Renal (Patho)Physiology.
    Silva-Aguiar RP; Peruchetti DB; Pinheiro AAS; Caruso-Neves C; Dias WB
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytical and Biochemical Perspectives of Protein O-GlcNAcylation.
    Ma J; Wu C; Hart GW
    Chem Rev; 2021 Feb; 121(3):1513-1581. PubMed ID: 33416322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.